In this clinical audit you will conduct a review of patients with pancreatic exocrine insufficiency (PEI) who are currently receiving PERT (pancreatic enzyme replacement therapy), in order to assess their quality of life and treatment effectiveness, and optimise their therapy.
In this two-part clinical audit, you will review your past management of patients with type 2 diabetes and overweight or obesity, then utilise your learnings to guide effective glycaemic and weight management of further patients.
Review your management of patients with HFrEF (heart failure with reduced ejection fraction) in this clinical audit, and update their treatment to be in line with latest recommendations including the "four pillars" approach.
This highly practical advanced course will help you to understand the science of obesity and overcome barriers to effective obesity management in your practice and is presented by A/Prof Gary Kilov AM and Dr Kevin Lee.
This clinical audit will guide GPs through the process of identifying patients for whom herpes zoster (HZ) vaccination is recommended, and outlines the evidence and current Australian recommendations for selecting the most appropriate type of HZ vaccine for each patient.
Food cravings are an intense desire to eat highly palatable and energy-dense foods and are among the main influencers of eating behaviour. In this module you will learn best practice steps to manage patients, then undertake a practical exercise to identify a patient who is overweight or living with obesity from your practice in order to reflect on latest evidence.
In this clinical audit, you will conduct an assessment of patients who are at risk of metabolic associated fatty liver disease (MAFLD), calculate their risk of liver fibrosis using validated tools and decide on further management.
Module 2 of 2: This two-part activity provides education on the various long-acting buprenorphine (LAIB) formulations available in Australia, followed by a practical exercise where the learner goes through the steps of assessing whether a patient is suitable for LAIB treatment, and discusses with them how treatment may help them achieve their goals.